Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Indian J Dermatol Venereol Leprol ; 87(4): 468-482, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34219433

RESUMEN

One of the canonical features of the current outbreak of dermatophytosis in India is its unresponsiveness to treatment in majority of cases. Though there appears to be discordance between in vivo and in vitro resistance, demonstration of in vitro resistance of dermatophytes to antifungals by antifungal susceptibility testing is essential as it may help in appropriate management. The practical problem in the interpretation of antifungal susceptibility testing is the absence of clinical breakpoints and epidemiologic cutoff values. In their absence, evaluation of the upper limit of a minimal inhibitory concentration of wild type isolates may be beneficial for managing dermatophytosis and monitoring the emergence of isolates with reduced susceptibility. In the current scenario, most of the cases are unresponsive to standard dosages and duration of treatment recommended until now. This has resulted in many ex-cathedra modalities of treatment that are being pursued without any evidence. There is an urgent need to carry out methodical research to develop an evidence base to formulate a rational management approach in the current scenario.


Asunto(s)
Antifúngicos/uso terapéutico , Farmacorresistencia Fúngica , Tiña/tratamiento farmacológico , Adaptación Fisiológica/fisiología , Biopelículas , Epidemias , Hongos/fisiología , Humanos , India/epidemiología , Pruebas de Sensibilidad Microbiana , Mutación , Escualeno-Monooxigenasa/genética , Tiña/epidemiología
2.
Indian J Dermatol Venereol Leprol ; 87(2): 154-175, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33769736

RESUMEN

Dermatophytosis has attained unprecedented dimensions in recent years in India. Its clinical presentation is now multifarious, often with atypical morphology, severe forms and unusually extensive disease in all age groups. We hesitate to call it an epidemic owing to the lack of population-based prevalence surveys. In this part of the review, we discuss the epidemiology and clinical features of this contemporary problem. While the epidemiology is marked by a stark increase in the number of chronic, relapsing and recurrent cases, the clinical distribution is marked by a disproportionate rise in the number of cases with tinea corporis and cruris, cases presenting with the involvement of extensive areas, and tinea faciei.


Asunto(s)
Tiña/epidemiología , Distribución por Edad , Abuso de Medicamentos , Escolaridad , Glucocorticoides/efectos adversos , Humanos , Enfermedad Iatrogénica , Incidencia , India/epidemiología , Ocupaciones , Prevalencia , Calidad de Vida , Recurrencia , Factores de Riesgo , Población Rural , Distribución por Sexo , Clase Social , Tiña/diagnóstico , Población Urbana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA